SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-035069
Filing Date
2021-03-11
Accepted
2021-03-11 17:00:42
Documents
2
Period of Report
2021-03-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm219431-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm219431-1_3seq1.xml 3 1598
2 EXHIBIT 24 tm219431d1_ex24.htm EX-24 7767
  Complete submission text file 0001104659-21-035069.txt   10841
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLENA PHARMACEUTIALS, INC. ONEW NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address
Diaz Allene M. (Reporting) CIK: 0001773314 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38129 | Film No.: 21734032